Stay updated on Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5 on the page, signaling an internal update to the study record. This change does not alter the study details, eligibility criteria, locations, or outcomes displayed to users.
    Difference
    0.0%
    Check dated 2026-06-05T10:03:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and the previous Revision: v3.5.3 was removed, reflecting an update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-05-15T05:39:03.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s interface/display revision was updated from **v3.5.2** to **v3.5.3**, indicating a site version change rather than a change to the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:36:22.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:52:21.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Updated the listed location from Padua, PD, Italy, 35128 to Padova, PD, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-09T21:53:03.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-19T08:35:44.000Z thumbnail image

Stay in the know with updates to Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.